RACHEL PRICE: Open Payments
NPI 1679120273 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 10 companies in 2025. Trend: 2023 $107 · 2024 $619 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $48 |
| ABBVIE INC. | 3 | $47 |
| Exact Sciences Corporation | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REXULTI, QULIPTA, Cologuard Collection Kit, FANAPT, Wegovy, CAPLYTA, ZENPEP, XIFAXAN.
Industry payments across MI — which companies pay providers there.
